Efficacy of Platelet-Rich Plasma in the Treatment of Knee Osteoarthritis: A Meta-analysis of Randomized Controlled Trials

Arthroscopy - Journal of Arthroscopic and Related Surgery

Volumn 33, Issue 3, 2017, Pages 659-670.e1

  Dai, Wen Li ^a   Zhou, Ai Guo ^a   Zhang, Hua ^a   Zhang, Jian ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID; SODIUM CHLORIDE; VISCOSUPPLEMENT;

ANALGESIA; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL OUTCOME; COCHRANE LIBRARY; EFFECT SIZE; EMBASE; HUMAN; KNEE OSTEOARTHRITIS; MEDLINE; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SYSTEMATIC REVIEW (TOPIC); THROMBOCYTE RICH PLASMA; WESTERN ONTARIO AND MCMASTER UNIVERSITIES OSTEOARTHRITIS INDEX; INTRAARTICULAR DRUG ADMINISTRATION; OSTEOARTHRITIS, KNEE; PAIN MEASUREMENT;

HUMANS; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; OSTEOARTHRITIS, KNEE; PAIN MEASUREMENT; PLATELET-RICH PLASMA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VISCOSUPPLEMENTS;

EID: 85010680362     PISSN: 07498063     EISSN: 15263231     Source Type: Journal    
DOI: 10.1016/j.arthro.2016.09.024     Document Type: Article

References (63)

1. 1 Cross, M., Smith, E., Hoy, D., et al. The global burden of hip and knee osteoarthritis: Estimates from the global burden of disease 2010 study. Ann Rheum Dis 73 (2014), 1323–1330.
2. 2 Haywood, L., Mcwilliams, D.F., Pearson, C.I., et al. Inflammation and angiogenesis in osteoarthritis. Arthritis Rheum 48 (2003), 2173–2177.
3. 3 Dieppe, P.A., Lohmander, L.S., Pathogenesis and management of pain in osteoarthritis. Lancet 365 (2005), 965–973.
4. 4 Johnson, V.L., Hunter, D.J., The epidemiology of osteoarthritis. Best Pract Res Clin Rheumatol 28 (2014), 5–15.
5. 5 Carr, A.J., Robertsson, O., Graves, S., et al. Knee replacement. Lancet 379 (2012), 1331–1340.
6. 6 Bijlsma, J.W., Berenbaum, F., Lafeber, F.P., Osteoarthritis: An update with relevance for clinical practice. Lancet 377 (2011), 2115–2126.
7. 7 Richmond, J., Hunter, D., Irrgang, J., et al. American Academy of Orthopaedic Surgeons clinical practice guideline on the treatment of osteoarthritis (OA) of the knee. J Bone Joint Surg Am 92 (2010), 990–993.
8. 8 McAlindon, T.E., Bannuru, R.R., Sullivan, M.C., et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage 22 (2014), 363–388.
9. 9 Boswell, S.G., Cole, B.J., Sundman, E.A., Karas, V., Fortier, L.A., Platelet-rich plasma: A milieu of bioactive factors. Arthroscopy 28 (2012), 429–439.
10. 10 Sundman, E.A., Cole, B.J., Karas, V., et al. The anti-inflammatory and matrix restorative mechanisms of platelet-rich plasma in osteoarthritis. Am J Sports Med 42 (2014), 35–41.
11. 11 Cugat, R., Cusco, X., Seijas, R., et al. Biologic enhancement of cartilage repair: The role of platelet-rich plasma and other commercially available growth factors. Arthroscopy 31 (2015), 777–783.
12. 12 Spreafico, A., Chellini, F., Frediani, B., et al. Biochemical investigation of the effects of human platelet releasates on human articular chondrocytes. J Cell Biochem 108 (2009), 1153–1165.
13. 13 Anitua, E., Sanchez, M., Orive, G., Andia, I., The potential impact of the preparation rich in growth factors (PRGF) in different medical fields. Biomaterials 28 (2007), 4551–4560.
14. 14 Pettersson, S., Wettero, J., Tengvall, P., Kratz, G., Human articular chondrocytes on macroporous gelatin microcarriers form structurally stable constructs with blood-derived biological glues in vitro. J Tissue Eng Regen Med 3 (2009), 450–460.
15. 15 Kon, E., Filardo, G., Di Martino, A., Marcacci, M., Platelet-rich plasma (PRP) to treat sports injuries: Evidence to support its use. Knee Surg Sports Traumatol Arthrosc 19 (2011), 516–527.
16. 16 Milano, G., Deriu, L., Sanna Passino, E., et al. Repeated platelet concentrate injections enhance reparative response of microfractures in the treatment of chondral defects of the knee: An experimental study in an animal model. Arthroscopy 28 (2012), 688–701.
17. 17 Kon, E., Mandelbaum, B., Buda, R., et al. Platelet-rich plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: From early degeneration to osteoarthritis. Arthroscopy 27 (2011), 1490–1501.
18. 18 Filardo, G., Kon, E., Di Martino, A., et al. Platelet-rich plasma vs hyaluronic acid to treat knee degenerative pathology: Study design and preliminary results of a randomized controlled trial. BMC Musculoskelet Disord, 13, 2012, 229.
19. 19 Spakova, T., Rosocha, J., Lacko, M., Harvanova, D., Gharaibeh, A., Treatment of knee joint osteoarthritis with autologous platelet-rich plasma in comparison with hyaluronic acid. Am J Phys Med Rehabil 91 (2012), 411–417.
20. 20 Higgins J. Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0. 2011. http://handbook.cochrane.org/. Accessed April 30, 2016.
21. 21 Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ, 339, 2009, b2535.
22. 22 Altman, R., Asch, E., Bloch, D., et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Arthritis Rheum 29 (1986), 1039–1049.
23. 23 McConnell, S., Kolopack, P., Davis, A.M., The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC): A review of its utility and measurement properties. Arthritis Rheum 45 (2001), 453–461.
24. 24 Higgins, L.D., Taylor, M.K., Park, D., et al. Reliability and validity of the International Knee Documentation Committee (IKDC) Subjective Knee Form. Joint Bone Spine 74 (2007), 594–599.
25. 25 Lequesne, M.G., Mery, C., Samson, M., Gerard, P., Indexes of severity for osteoarthritis of the hip and knee. Validation—value in comparison with other assessment tests. Scand J Rheumatol Suppl 65 (1987), 85–89.
26. 26 Landis, J.R., Koch, G.G., The measurement of observer agreement for categorical data. Biometrics 33 (1977), 159–174.
27. 27 Doganay Erdogan, B., Leung, Y.Y., Pohl, C., Tennant, A., Conaghan, P.G., Minimal clinically important difference as applied in rheumatology: An OMERACT Rasch Working Group systematic review and critique. J Rheumatol 43 (2016), 194–202.
28. 28 Jaeschke, R., Singer, J., Guyatt, G.H., Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 10 (1989), 407–415.
29. 29 Angst, F., Aeschlimann, A., Stucki, G., Smallest detectable and minimal clinically important differences of rehabilitation intervention with their implications for required sample sizes using WOMAC and SF-36 quality of life measurement instruments in patients with osteoarthritis of the lower extremities. Arthritis Rheum 45 (2001), 384–391.
30. 30 Tubach, F., Ravaud, P., Martin-Mola, E., et al. Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: Results from a prospective multinational study. Arthritis Care Res (Hoboken) 64 (2012), 1699–1707.
31. 31 Hmamouchi, I., Allali, F., Tahiri, L., et al. Clinically important improvement in the WOMAC and predictor factors for response to non-specific non-steroidal anti-inflammatory drugs in osteoarthritic patients: a prospective study. BMC Res Notes, 5, 2012, 58.
32. 32 Higgins, J.P., Thompson, S.G., Deeks, J.J., Altman, D.G., Measuring inconsistency in meta-analyses. BMJ 327 (2003), 557–560.
33. 33 Egger, M., Davey Smith, G., Schneider, M., Minder, C., Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997), 629–634.
34. 34 Begg, C.B., Mazumdar, M., Operating characteristics of a rank correlation test for publication bias. Biometrics 50 (1994), 1088–1101.
35. 35 Cerza, F., Carni, S., Carcangiu, A., et al. Comparison between hyaluronic acid and platelet-rich plasma, intra-articular infiltration in the treatment of gonarthrosis. Am J Sports Med 40 (2012), 2822–2827.
36. 36 Duymus TM, Mutlu S, Dernek B, Komur B, Aydogmus S, Kesiktas FN. Choice of intra-articular injection in treatment of knee osteoarthritis: Platelet-rich plasma, hyaluronic acid or ozone options [published online April 7, 2016]. Knee Surg Sports Traumatol Arthrosc. doi: 10.1007/s00167-016-4110-5.
37. 37 Filardo, G., Di Matteo, B., Di Martino, A., et al. Platelet-rich plasma intra-articular knee injections show no superiority versus viscosupplementation: a randomized controlled trial. Am J Sports Med 43 (2015), 1575–1582.
38. 38 Gormeli G, Gormeli CA, Ataoglu B, Colak C, Aslanturk O, Ertem K. Multiple PRP injections are more effective than single injections and hyaluronic acid in knees with early osteoarthritis: A randomized, double-blind, placebo-controlled trial [published online August 2, 2015]. Knee Surg Sports Traumatol Arthrosc. doi: 10.1007/s00167-015-3705-6.
39. 39 Patel, S., Dhillon, M.S., Aggarwal, S., Marwaha, N., Jain, A., Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: A prospective, double-blind, randomized trial. Am J Sports Med 41 (2013), 356–364.
40. 40 Paterson, K.L., Nicholls, M., Bennell, K.L., Bates, D., Intra-articular injection of photo-activated platelet-rich plasma in patients with knee osteoarthritis: A double-blind, randomized controlled pilot study. BMC Musculoskelet Disord, 17, 2016, 67.
41. 41 Raeissadat, S.A., Rayegani, S.M., Hassanabadi, H., et al. Knee osteoarthritis injection choices: Platelet-rich plasma (PRP) versus hyaluronic acid (a one-year randomized clinical trial). Clin Med Insights Arthritis Musculoskelet Disord 8 (2015), 1–8.
42. 42 Sanchez, M., Fiz, N., Azofra, J., et al. A randomized clinical trial evaluating plasma rich in growth factors (PRGF-Endoret) versus hyaluronic acid in the short-term treatment of symptomatic knee osteoarthritis. Arthroscopy 28 (2012), 1070–1078.
43. 43 Smith, P.A., Intra-articular autologous conditioned plasma injections provide safe and efficacious treatment for knee osteoarthritis: An FDA-sanctioned, randomized, double-blind, placebo-controlled clinical trial. Am J Sports Med 44 (2016), 884–891.
44. 44 Vaquerizo, V., Plasencia, M.A., Arribas, I., et al. Comparison of intra-articular injections of plasma rich in growth factors (PRGF-Endoret) versus Durolane hyaluronic acid in the treatment of patients with symptomatic osteoarthritis: A randomized controlled trial. Arthroscopy 29 (2013), 1635–1643.
45. 45 Lopez-Vidriero, E., Goulding, K.A., Simon, D.A., Sanchez, M., Johnson, D.H., The use of platelet-rich plasma in arthroscopy and sports medicine: Optimizing the healing environment. Arthroscopy 26 (2010), 269–278.
46. 46 Mei-Dan, O., Carmont, M.R., Laver, L., Mann, G., Maffulli, N., Nyska, M., Platelet-rich plasma or hyaluronate in the management of osteochondral lesions of the talus. Am J Sports Med 40 (2012), 534–541.
47. 47 Warth, R.J., Dornan, G.J., James, E.W., Horan, M.P., Millett, P.J., Clinical and structural outcomes after arthroscopic repair of full-thickness rotator cuff tears with and without platelet-rich product supplementation: A meta-analysis and meta-regression. Arthroscopy 31 (2015), 306–320.
48. 48 Figueroa, D., Figueroa, F., Calvo, R., Vaisman, A., Ahumada, X., Arellano, S., Platelet-rich plasma use in anterior cruciate ligament surgery: Systematic review of the literature. Arthroscopy 31 (2015), 981–988.
49. 49 Ornetti, P., Nourissat, G., Berenbaum, F., Sellam, J., Richette, P., Chevalier, X., Does platelet-rich plasma have a role in the treatment of osteoarthritis?. Joint Bone Spine 83 (2016), 31–36.
50. 50 Petrera, M., De Croos, J.N., Iu, J., Hurtig, M., Kandel, R.A., Theodoropoulos, J.S., Supplementation with platelet-rich plasma improves the in vitro formation of tissue-engineered cartilage with enhanced mechanical properties. Arthroscopy 29 (2013), 1685–1692.
51. 51 Kreuz, P.C., Kruger, J.P., Metzlaff, S., et al. Platelet-rich plasma preparation types show impact on chondrogenic differentiation, migration, and proliferation of human subchondral mesenchymal progenitor cells. Arthroscopy 31 (2015), 1951–1961.
52. 52 Filardo, G., Kon, E., Buda, R., et al. Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis. Knee Surg Sports Traumatol Arthrosc 19 (2011), 528–535.
53. 53 Meheux, C.J., McCulloch, P.C., Lintner, D.M., Varner, K.E., Harris, J.D., Efficacy of intra-articular platelet-rich plasma injections in knee osteoarthritis: A systematic review. Arthroscopy 32 (2016), 495–505.
54. 54 Martin, P., Leibovich, S.J., Inflammatory cells during wound repair: The good, the bad and the ugly. Trends Cell Biol 15 (2005), 599–607.
55. 55 Scott, A., Khan, K.M., Roberts, C.R., Cook, J.L., Duronio, V., What do we mean by the term “inflammation”? A contemporary basic science update for sports medicine. Br J Sports Med 38 (2004), 372–380.
56. 56 Wells, G., Beaton, D., Shea, B., et al. Minimal clinically important differences: Review of methods. J Rheumatol 28 (2001), 406–412.
57. 57 Wells, G., Anderson, J., Beaton, D., et al. Minimal clinically important difference module: Summary, recommendations, and research agenda. J Rheumatol 28 (2001), 452–454.
58. 58 Crosby, R.D., Kolotkin, R.L., Williams, G.R., Defining clinically meaningful change in health-related quality of life. J Clin Epidemiol 56 (2003), 395–407.
59. 59 Zlowodzki, M., Bhandari, M., Outcome measures and implications for sample-size calculations. J Bone Joint Surg Am 91:suppl 3 (2009), 35–40.
60. 60 Khoshbin, A., Leroux, T., Wasserstein, D., et al. The efficacy of platelet-rich plasma in the treatment of symptomatic knee osteoarthritis: A systematic review with quantitative synthesis. Arthroscopy 29 (2013), 2037–2048.
61. 61 Laudy, A.B., Bakker, E.W., Rekers, M., Moen, M.H., Efficacy of platelet-rich plasma injections in osteoarthritis of the knee: A systematic review and meta-analysis. Br J Sports Med 49 (2015), 657–672.
62. 62 Moen, M., Weir, A., Bakker, E., Rekers, M., Laudy, G., Efficacy of platelet-rich plasma injections in osteoarthritis of the knee: An updated systematic review and meta-analysis. Osteoarthritis Cartilage 24 (2016), S520–S521.
63. 63 Chang, K.V., Hung, C.Y., Aliwarga, F., Wang, T.G., Han, D.S., Chen, W.S., Comparative effectiveness of platelet-rich plasma injections for treating knee joint cartilage degenerative pathology: A systematic review and meta-analysis. Arch Phys Med Rehabil 95 (2014), 562–575.